541 results about "N-Butyrate" patented technology

The present invention provides bioactive polymer compositions that can be formulated to release a wound healing agent at a controlled rate by adjusting the various components of the composition. The composition can be used in an external wound dressing, as a polymer implant for delivery of the wound healing agent to an internal body site, or as a coating on the surface of an implantable surgical device to deliver wound healing agents that are covalently attached to a biocompatible, biodegradable polymer and/or embedded within a hydrogel. Methods of using the invention bioactive polymer compositions to promote natural healing of wounds, especially chronic wounds, are also provided. Examples of biodegradable copolymer polyesters useful in forming the blood-compatible, hydrophilic layer or coating include copolyester amides, copolyester urethanes, glycolide-lactide copolymers, glycolide-caprolactone copolymers, poly-3-hydroxy butyrate-valerate copolymers, and copolymers of the cyclic diester monomer, 3-(S)[(alkyloxycarbonyl)methyl]-1,4-dioxane-2,5-dione, with L-lactide. The glycolide-lactide copolymers include poly(glycolide-L-lactide) copolymers formed utilizing a monomer mole ratio of glycolic acid to L-lactic acid ranging from 5:95 to 95:5 and preferably a monomer mole ratio of glycolic acid to L-lactic acid ranging from 45:65 to 95:5. The glycolide-caprolactone copolymers include glycolide and ε-caprolactone block copolymer, e.g., Monocryl or Poliglecaprone.

The invention provides a nonaqueous electrolyte material, which consists of fluorosulfonylimide lithium and organic solvent with dielectric constant less than 30, and the organic solvent is selected from one or more of chain-like carbonate solvent, phosphate solvent, siloxane solvent, boroxane solvent, acetate solvent, propionate solvent, butyrate solvent, CF3OCH2CH2OCF3 solvent, C2H5OCH2CH2OCH3 solvent, C2F5OCH2CH2OCF3 solvent, 1,3-dioxolane solvent and aliphatic nitrile solvent with more than two carbon atoms. The ionic conductivity of the nonaqueous electrolyte material is 0.01mS/cm to 18mS/cm, the lithium ion transference number is tLi plus equal to 0.2 to 0.8, and the applicable temperature range is 80DEG C below zero to 60DEG C below zero. The invention also provides an application of the nonaqueous electrolyte material in the preparation of lithium batteries and super capacitors. Furthermore, the invention provides a lithium battery and a super capacitor which contain the nonaqueous electrolyte material of fluorosulfonylimide lithium.

A composition of bio-active compounds and methods for facilitating and supporting the metabolism and transport of glucose and carbohydrates into muscle cells, promoting muscle function and growth, promoting glycogen synthesis, enhancing glucose disposal, stimulating pancreatic beta cells, promoting metabolic recovery, promoting muscle recovery, promoting lean body mass, and promoting fat burning. Preferably, the composition of bio-active compounds includes a combination of 4-hydroxyisoleucine with at least one amino acid selected from the group consisting of arginine, aspartate, threonine, serine, glutamate, proline, glycine, alanine, cysteine, valine, methionine, isoleucine, leucine, tryptophan, phenylalanine, ornithine, lysine, histidine, gamma-amino butyrate and tyrosine. In one presently preferred embodiment of the present invention, the combination is derived, isolated, and/or extracted from fenugreek seeds. Methods for using a novel composition of bio-active compounds from fenugreek seed for facilitating and supporting the metabolism and transport of glucose and carbohydrates into muscle cells, promoting muscle function and growth, promoting glycogen synthesis, enhancing glucose disposal, stimulating pancreatic beta cells, promoting metabolic recovery, promoting muscle recovery, promoting lean body mass, and promoting fat burning are also disclosed, wherein methods comprise the steps of: (1) providing an effective amount of a composition of bio-active compounds derived, isolated, and/or extracted from fenugreek seeds; and (2) administering the composition to a human or animal.

Compositions and lures are described which provide vapor blends of acetic acid and one or more compounds selected from the group consisting of isobutanol, racemic 2-methyl-1-butanol, S-(-)-2-methyl-1-butanol, 2-methyl-2-propanol, heptyl butyrate, and butyl butyrate which function as highly effective attractants for yellowjacket wasps and paper wasps. By attracting wasps to traps or baits, the chemical attractants provide a means for detecting, surveying, monitoring, and controlling the wasps.

There is provided in one embodiment of the invention an electrolyte for use in a lithium ion electrochemical cell. The electrolyte comprises a mixture of an ethylene carbonate (EC), an ethyl methyl carbonate (EMC), an ester cosolvent, and a lithium salt. The ester cosolvent comprises methyl propionate (MP), ethyl propionate (EP), methyl butyrate (MB), ethyl butyrate (EB), propyl butyrate (PB), or butyl butyrate (BB). The electrochemical cell operates in a temperature range of from about −60 degrees Celsius to about 60 degrees Celsius. In another embodiment there is provided a lithium ion electrochemical cell using the electrolyte of the invention.

The invention as disclosed herein provides pharmaneutical compositions and methods for treating, ameliorating, or preventing the symptoms of Parkinson's Disease. The pharmaneutical compositions of the invention contain in an effective amount a first and a second composition, the first composition comprises an effective amount of one or more phosphatidylcholine formulations and the second composition comprises an effective amount of one or more constituents comprising essential fatty acid supplements, trace minerals, butyrate, electrolytes, methylating agents, reduced glutathione, or a combination thereof, in a suitable carrier.

The invention discloses a method for preparing butyrate clevidipine. The method comprises that 2, 3-dichlorobenzaldehyde, acetoacetate propionitrile ester and 3-amino-2-methyl crotonate are mixed and one-pot Hantzsch reaction is conducted, base catalyst is added to remove 2-cyanoethyl to obtain key intermediate, the key intermediate reacts with n-butyric acid chloromethyl ester to obtain butyrate clevidipine crude product, and the crude product is recrystallized to obtain high-purity butyrate clevidipine. Raw material 3-amino-2-methyl crotonate can be prepared by using low-price methyl acetoacetate. Raw material acetoacetate propionitrile ester can be prepared by using diketene. The synthesis of all raw materials requires no chromatographic separation for purification. The intermediate is synthesized through one-pot Hantzsch reaction, the reaction speed is fast, the condition is mild, the technological reliability is high and the purity of the intermediate is high. The conditions for the reaction of the key intermediate and the n-butyric acid chloromethyl ester can be easily controlled, the operation is simple and convenient, the cost is low, the post treatment requires no chromatographic separation for purification, the purity of the obtained butyrate clevidipine is above 99.5 percent and the mass production can be realized.

A liquid crystal device having a plurality of pixel electrodes for transmitting light, a first panel having an activation portion for selectively activating the plurality of pixel electrodes, an orientation layer formed on the activation portion, a light shielding pattern formed on the orientation layer, a second panel having a second orientation layer, a liquid crystal formed between the first and second panels, a polarizing plate or a color filter and a protective film on at least one of the aforementioned surfaces wherein the protective layer includes a cellulose ester selected from the group consisting of cellulose acetate, cellulose formate, cellulose propionate, cellulose butyrate, ethyl cellulose, methyl cellulose and benzyl cellulose having an inherent viscosity of from about 1.0 to less than 2.0 dl/g.

The invention discloses a synthesis method of medicinal calcium D,L-2-hydroxyl-4-(methylthio)butyrate. By adopting the existing methods, the product has more impurities and poor quality; and some methods have harsh conditions and low product yield and are not suitable for industrial production. The synthesis method comprises the following steps: using feed grade D,L-2-hydroxyl-4-methylthiobutyricacid of which the content is less than 90% or D,L-2-hydroxyl-4-methylthiobutyric acid of which the content is 75-90% as a starting raw material to react with ammonia and generate an ammonium salt, performing dehydration to obtain D,L-2-hydroxyl-4-methylthiobutyramide, extracting, concentrating, crystallizing and purifying to obtain D,L-2-hydroxyl-4-methylthiobutyramide of which the content is more than 98.5%; and hydrolyzing to generate D,L-2-hydroxyl-4-methylthiobutyrate, and performing the salt forming reaction with CaX2 to generate calcium D,L-2-hydroxyl-4-(methylthio)butyrate. The synthesis method in the invention has mild process conditions, less side reactions and high yield.

Embodiments of the invention relate to a composition for controlling a target pest, wherein the composition includes at least two active ingredients selected from the group consisting of thymyl acetate, linalyl acetate, amyl butyrate, anise star oil, black seed oil, p-cymene, geraniol, isopropyl myristate, d-limonene, linalool, lilac flower oil, methyl salicylate, alpha-pinene, piperonal, piperonyl alcohol, tetrahydrolinalool, thyme oil white, thyme oil red, thymol, vanillin, and winter-green oil, wherein the composition causes synergistic control of the target pest.

The invention discloses a method for preparing a D, L-2-hydroxyl-4-methylthio butanoic calcium salt for medicinal purpose. The method comprises following steps of: a. using a D,L-2-hydroxyl-4-methylthio butanoic acid and an alcohol with a general formula of ROH as the raw materials to carry out esterification to obtain a D, L-2-hydroxyl-4-methylthio butyrate, and; b. hydrolyzing the D, L-2-hydroxyl-4-methylthio butyrate in step a and calcium oxide in a solvent to produce the D, L-2-hydroxyl-4-methylthio butanoic calcium salt. The method provided by the invention for the production of the D, L-2-hydroxyl-4-methylthio butanoic calcium salt has the advantages of short course, readily available the raw materials, low cost, easy control over the quality of the product, and more importantly, the method can prepare high-purity D, L-2-hydroxyl-4-methylthio butanoic calcium salt for medicinal purpose, thereby satisfying the requirements of State Food and Drug Administration Bureau and Good Manufacturing Practice (GMP) for drug production, and facilitating the preparation of pharmaceutical preparations.

Methods and compositions are provided for protecting exterior surfaces of automobiles and other products, or components of products, against abrasion, abrasive dust, water, acid rain, etc. The methods involve applying to a surface a protective coating composition comprising a polyvinyl butyrate emulsion and a relatively inert extender. The emulsion is dried to form a water-resistant protective coating that can be removed from the underlying surface by peeling when no longer desired.

The invention relates to a combination of treatments, more particularly a combination treatment for HIV-1 infection. The present invention is directed to the use of bryostatin-1 and their natural and synthetic derivatives for AIDS therapy, in particular to the use of bryostatins in combination with other active drugs such as Histone Deacetylases (HDACs) inhibitors and anti-retrovirals, for the treatment of HIV-1 latency. According to the present invention, we provide a combination therapy for the treatment of HIV-1 latency which employs bryostatin-1 (and analogues) and one of the following HDAC inhibitors; valproic acid, butyrate derivatives, hydroxamic acids and benzamides. While HDACi can be used in continuous dosing protocol, bryostatins can be used following a cyclical dosing protocol. Bryostatins can be formulated in pharmaceutical acceptable carriers including nanoparticles, phospholipids nanosomes and/or biodegradable polymer nanospheres. This combination therapy needs to be used in patients treated with antiretroviral therapy (HIV-1 protease inhibitors, HIV-1 reverse transcriptase inhibitors, HIV-1 integrase inhibitors, CCR5 co-receptor inhibitors and fusion inhibitors).

Methods for engineering transgenic organisms that synthesize polyhydroxyalkanoates (PHAs) containing 3-hydroxyhexanoate as comonomer have been developed. These processes are based on genetically engineered bacteria such as Escherichia coli or in plant crops as production systems which include PHA biosynthetic genes from PHA producers. In a preferred embodiment of the method, additional genes are introduced in wild type or transgenic polyhydroxybutyrate (PHB) producers, thereby creating new strains that synthesize 3HH monomers which are incorporated into PHAs. The 3HH monomer preferably is derived in microbial systems using butanol or butyrate as feedstocks, which are precursors of 3-hydroxyhexanoyl-CoA. Pathways for in vivo production of butyrol-CoA specifically encompassing butyryl-CoA dehydrogenase activity are provided.

The invention discloses a high temperature-resistant ceramics coating for non-stick cookware, and a preparation method of the coating. The coating is prepared by mixing A composition and B composition with the weight ratio of 2.0-2.2:1.0-1.2, wherein the A composition consists of silicon oxide colloidal sol, aluminum oxide colloidal sol, zirconium oxide colloidal sol, mica powder, iron oxide black, high-temperature aluminium oxide, isopropanol, deionized water, carboxymethyl acetic acid, cellulose butyrate and fluoro silicone oil, and the B composition consists of methyltriethoxysilane, dimethoxydimethylsilane, triethoxyphenylsilane, isopropanol and ethanol; the preparation method comprises the steps of: and mixing the A composition and B composition with the weight ratio of 2.0-2.2:1.0-1.2, hermetically stirring and curing under 35 DEG C 150-200rpm state for at least three hours, thus obtaining the coating. For the high temperature-resistant ceramics coating, the high temperature-resistant stability of -Si-O0 bond is mainly utilized, so that the excellent high temperature-resistant performance of the coating is guaranteed.

This invention pertains to a method for flavoring an ingestible composition with a flavoring agent in organoleptically purified form, unaccompanied by substances of natural origin present in mango. The flavoring agent may be used in a wide variety of ingestible vehicles such as chewing gum compositions, hard and soft confections, dairy products, beverage products including juice drinks and juice products, green vegetable and chicken products, and the like. The present invention also pertains to an ingestible composition comprising an ingestible vehicle and an organoleptically effective amount of the purified flavoring agent. The present invention also pertains to ethyl 4-(thioacetoxy)butyrate represented by the formula, CH₃COS(CH₂)₃COOCH₂CH₃.

The invention relates to a lithium iron phosphate battery with lithium ion battery electrolyte suitable for ultralow-temperature charging and discharging. The lithium ion battery electrolyte comprises lithium salt, a multi-element organic solvent and additives, wherein the additives comprise a low-melting-point additive, a film forming additive and a high-temperature additive; the multi-element organic solvent contains at least three of ethylene carbonate, diethyl carbonate, dimethyl carbonate, methyl ethyl carbonate, propylene carbonate and butylene carbonate; the low-melting-point additive contains at least one of 4-methyl-1,3-dioxolane, methyl acetate, methyl propionate, methyl butyrate, ethyl butyrate, propyl butyrate and butyl acetate; the high-temperature additive is at least one of methyl ester, di-n-propyl carbonate and 1,3-propane sultone. The lithium iron phosphate battery with the electrolyte can charge and discharge at an ultralow temperature and in a high-temperature environment, and is stable in performance and long in recycling life.

The present invention provides a flavoured product comprising four or more flavour materials having antimicrobial properties and selected from the group comprising nonanol, decanol, nonanal, decanal, amyl propionate, anethole synthetic, anisic aldehyde, basil oil, benzyl benzoate, benzyl butyrate, benzyl formate, camomile oil, cinnamic aldehyde, cis-3-hexenol, clove bud oil, damascone, ethyl acetoacetate, eucalyptus oil, ginger, isoamyl acetate, menthol laevo, methyl cinnamate, methyl salicylate, orange oil, rosemary oil, tarragon, Tea Tree oil, and peppermint oil; and one or more antimicrobial agents selected from the group comprising triclosan, pyrophosphates, zinc salts, cetylpyridinium chloride, parabens, stannous salts, sodium dodecyl sulphate, chlorhexidine, copper salts, strontium salts, peroxides and sanguinarine.

The invention discloses a method for preparing organic cellulose acid ester by solid acid catalysts, relating to the technical field for preparing organic cellulose acid ester. In the invention, the organic cellulose acid ester refers to cellulose formic acid, cellulose acetate, cellulose propionate, cellulose acetate butyrate, cellulose acetate propionate, cellulose acetate butyrate and cellulose acetate propionate butyrate. Three solid acids, namely, SO42-/MxOy solid acid, biomass carbon-based solid acid, phosphorus-aluminum molecular sieve solid acid; the organic acid is used as solvent and the organic acid anhydride is used as esterifying agent; the using amount of the catalyst is 0.01-5% of the reaction liquid; the organic cellulose acid ester is prepared under the conditions that the reaction temperature is 15-90 DEG C and the reaction time is 0.5-72 h. The method adopts the novel environment-friendly solid acid catalyst; the obtained product has good quality; the catalyst is easy to separate, recover and recycle; no device corrosion exists and the environment is protected.

The invention discloses sitagliptin and an enzyme-chemical preparation method of an intermediate of the sitagliptin. The method comprises the steps of mixing 3-carbonyl-4-(2, 4, 5-trifluoro-phenyl)butyrate, D-amino acid dehydrogenase, a cofactor, cofactor-catalyzing cyclophorase, an amino doner, a cosolvent and a buffer solution according to a certain ratio to obtain a product (R)-3-amino-4-(2, 4, 5 trifluoro-phenyl)butyrate; enabling the (R)-3-amino-4-(2, 4, 5 trifluoro-phenyl)butyrate to be subjected to the steps of amino protection, condensation and deprotection to obtain sitagliptin free alkali. Compared with the prior art, the method adopted by the invention is less in process route, shorter in reaction time, improved in product purity and yield and lower in production cost, and is suitable for industrial production.

The invention discloses an oil gas field exploitation used compound inhibitor and the preparation method. The compound inhibitor contains imidazolinyl organic phosphate, 2 - N-acid butyrate -1, 2, 4-tricarboxylic acid, thiourea, cetylpyridinium chloride. The mixture proportions of all constituents by weight can meet the specified contents of all active substances. The preparation method is that the 2 - N-acid butyrate -1, 2, 4 - tricarboxylic acid is added into imidazolinyl organic phosphate; thiourea is added into and dissolved into water; the solutions obtained by sub-steps are mixed together and are added into the cetylpyridinium chloride; after evenly stirring for 50-90 minutes and keeping the temperature rang within 15-45 DEG C, the inhibitor of the invention is produced. The compound inhibitor uses multifold medicaments for synergia, can prevent scale formation, can kill bacteria or inhabit bacteria from growing with less usage, can be applied to wide range, and can perform excellent efficiency under complex water quality condition.

The invention relates to a synthesizing method for pesticide glufosinate, i.e., ((D,L)-2-amino-4-(hydroxyl(methyl)phosphinyl)butyrate) and a salt of an acid or an alkali thereof. In the synthesizing method, the pesticide glufosinate is prepared by undergoing a strecker reaction, and an intermediate compound, i.e., (3-nitrile-3-hydroxy)propyl methyl phosphonic acid directly reacts with carbon dioxide and ammonia gas in an aqueous solution to synthesize the pesticide glufosinate and a salt of an acid or an alkali thereof. The method comprises the following specific steps of: adding the intermediate compound, i.e., (3-nitrile-3-hydroxy) propyl methyl phosphonic acid into a high-pressure kettle; adding carbon dioxide, ammonia gas and water, wherein ammonium bicarbonate or ammonium carbonate and the like can be used for replacing carbon dioxide carbon and ammonium, the molar ratio of the intermediate to the carbon dioxide is between 1 and 12, and the ratio of the ammonia gas to the carbon dioxide is between 0.5 and 5; adding 15-75 times of water; heating to 120-180 DEG C; reacting for about 4-20 hours; and after the reaction, cooling, taking the reaction liquid out, and concentrating to directly obtain an ammonium salt of glufosinate. The yield is over 80 percent.

The invention discloses a preparation method of sitagliptin intermediate, sitagliptin or salts thereof. The method comprises the following steps of: (1) preparing a compound, namely 2,4,5-trifluorobromobenzene shown as a formula (II) into a Grignard reagent; (2) reacting the Grignard reagent with boric acid trimester in an organic solvent under the action of a catalyst to obtain a compound, namely 2,4,5-trifluorobenzolc acid shown as a formula (III); and (3) preparing a compound, namely (3R)-3-substituted amido-4-bromine-butyric ester shown as a formula (IV) and the 2,4,5-trifluorobenzolc acid shown as the formula (II) into a compound, namely (3R)-3-substituted amido-4-(2,4,5-trifluorophenyl)-butyric ester shown as a formula (V) under the action of a transition metal catalyst and alkali. By using the method, the synthesis efficiency is increased, and the cost is lowered.

The invention relates to blends of polyolefins and a biodegradable polymer, such as polylactic acid (PLA) and polyhydroxy butyrate, which are compatabilized by a functionalized olefin (meth)acrylic copolymer. Since PLA and polyolefins are not miscible, the use of the compatibilzer improves the compatibility, thereby improving the processability, and particularly the melt strength and melt elasticity. Useful compatibilizers include Lotader® and Lotryl® copolymers from Arkema, Inc. The blend composition may optionally contain one or more acrylic copolymers as impact modifiers or process aids.